We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Releases Final Guidances on Management of Drug Risks
FDA Releases Final Guidances on Management of Drug Risks
April 1, 2005
The FDA’s three final guidances on minimizing safety risks of prescription drugs and biologics aim to make the agency’s risk management decisionmaking process more transparent, according to a top FDA official who also assured drugmakers that the recommendations are not expected to lengthen the product-approval process.